Memphis Pharmaceutical’s profits soar 188% in 6 months

Updated 1/30/2023 2:59:00 PM
Memphis Pharmaceutical’s profits soar 188% in 6 months

Arab Finance: Memphis Pharmaceutical’s (MPCI) profits after tax amounted to EGP 27.56 million in the six-month period ended December 31st, 2022, up by 188% year-on-year (YoY) from EGP 9.59 million, according to the financial income statement filed to the Egyptian Exchange (EGX) on January 30th.

Sales saw an 18% hike in the July-December period of 2022 to EGP 302.65 million, compared to EGP 257.23 million in the year-ago period.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Related News

EGX closes Tuesday’s session in red zone Updated 7/1/2025 3:00:00 PM
EGX shows mixed performance on Monday Updated 6/30/2025 3:18:00 PM
EGX sees bullish trend on Sunday Updated 6/29/2025 3:17:00 PM
EGX shows positive performance on Wednesday Updated 6/25/2025 2:59:00 PM